Literature DB >> 17137991

Determining whether delayed nonarteritic ischemic optic neuropathy associated with cataract extraction is a true entity.

Ly T Nguyen1, Michael J Taravella, Victoria S Pelak.   

Abstract

PURPOSE: To evaluate cases of delayed nonarteritic anterior and posterior ischemic optic neuropathy after cataract extraction and to evaluate the need for centralized prospective reporting of nonarteritic ischemic optic neuropathy after cataract extraction.
SETTING: Neuro-ophthalmology Clinics, University of Colorado Health Sciences Center and Denver Veterans Affairs Medical Center, Denver, Colorado, USA.
METHODS: A retrospective review of all patients referred to the Neuro-ophthalmology Divisions, University of Colorado Health Sciences Center and Denver Veterans Affairs Medical Center, from January 2001 to October 2005 was performed. All patients with a diagnosis of nonarteritic anterior or posterior ischemic optic neuropathy were identified. Patients with ischemic optic neuropathy that occurred between 2 months and 12 months after cataract extraction were selected for evaluation.
RESULTS: Six eyes with nonarteritic ischemic optic neuropathy that occurred 2 to 6 months after cataract extraction in 4 patients (2 bilateral nonarteritic ischemic optic neuropathy) and 1 eye with nonarteritic ischemic optic neuropathy that occurred after 6 months in 1 patient were identified. One patient had nonarteritic ischemic optic neuropathy in 1 eye 3 months after cataract extraction and 4 years later had nonarteritic ischemic optic neuropathy in the fellow eye 5 months after cataract extraction. Follow-up after the last cataract extraction was 1 to 3 years for all patients.
CONCLUSIONS: Although an association between cataract extraction and delayed nonarteritic anterior and posterior ischemic optic neuropathy has been suggested, current data do not support a causal relationship. In addition, the window of postoperative susceptibility for delayed ischemic optic neuropathy after cataract extraction is unclear.

Entities:  

Mesh:

Year:  2006        PMID: 17137991     DOI: 10.1016/j.jcrs.2006.08.028

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

1.  Effect of simulated dynamic intraocular pressure on retinal thickness measured by optical coherence tomography after cataract surgery.

Authors:  Ding Chen; Jun Zhu; Jin Li; Xi-Xia Ding; Fan Lu; Yun-E Zhao
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

2.  Retinal vessel diameter changes induced by transient high perfusion pressure.

Authors:  Yin-Ying Zhao; Ping-Jun Chang; Fang Yu; Yun-E Zhao
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

3.  Silent Post Cataract Bilateral Sequential Nonarteritic Anterior Ischaemic Optic Neuropathy.

Authors:  Étienne Bénard-Séguin; Lawrence Weisbrod; Arun Ne Sundaram
Journal:  Neuroophthalmology       Date:  2019-03-28

4.  Elevated intraocular pressure causes cellular and molecular retinal injuries, advocating a more moderate intraocular pressure setting during phacoemulsification surgery.

Authors:  Zhenni Zhao; Xiaowei Yu; Xue Yang; Jiamin Zhang; Dandan Zhang; Nannan Sun; Zhigang Fan
Journal:  Int Ophthalmol       Date:  2020-07-28       Impact factor: 2.031

5.  Real-time intraocular pressure measurement during phacoemulsification in dogs ex vivo.

Authors:  Seonmi Kang; Sangwan Park; Hyunwoo Noh; Jiyoon Kwak; Kangmoon Seo
Journal:  J Vet Med Sci       Date:  2015-02-16       Impact factor: 1.267

6.  The risk of ischemic optic neuropathy post phacoemulsification cataract surgery.

Authors:  Mousa Victor Al-Madani; Nancy Khalaf Al-Raqqad; Naser Abdallah Al-Fgarra; Amal Mousa Al-Thawaby; Ahmed Abdelra'of Jaafar
Journal:  Pan Afr Med J       Date:  2017-09-21

7.  A Population-Based Study of Anterior Ischemic Optic Neuropathy Following Cataract Surgery.

Authors:  Sasha A Mansukhani; John J Chen; Aaron M Fairbanks; Robert C Foster; Jay C Erie; Keith H Baratz; David O Hodge; M Tariq Bhatti
Journal:  Am J Ophthalmol       Date:  2020-08-18       Impact factor: 5.488

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.